🇪🇺 Litfulo in European Union

Litfulo (ritlecitinib) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006025
  • Local brand name: Litfulo
  • Status: approved

Litfulo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in European Union

Frequently asked questions

Is Litfulo approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Litfulo in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.